The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Link Between Vitamin D Deficiency And Pneumonia Deaths
Researchers in New Zealand have found that severe vitamin D deficiency is associated with a higher mortality among pneumonia patients, but no causal relationship has been proven.
Sanofi And DNDi To Tackle Nine Neglected Tropical Diseases
Sanofi and the Drugs for Neglected Diseases initiative will develop new treatments for nine neglected tropical diseases listed by the World Health Organization.
Davos Life Sciences Takes Tocotrienol Product Into Phase I Trials
Davos Life Science announced today preliminary results of a Phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.
22-Year-Old Student From Monash University Finds Universe’s Missing Mass
A Monash student has made a breakthrough in the field of astrophysics, discovering what has until now been described as the Universe's 'missing mass.'
Kidney Disease Most Common In Asian Populations
Researchers have identified five genomic regions that increase susceptibility to IgA nephropathy, a major cause of kidney failure worldwide.
Essential Protein Controls Inflammation In Cancer
Scientists have discovered an essential protein called 'Sharpin' that controls the inflammation induced by tumor necrosis factor.
Korean Scientists Map New Lung Cancer Therapeutic Target
Seoul National University researchers have found that high expressions of the protein variant of AIMP2 correlates lower survival rates in lung cancer patients.
IBN And IBM Fight Superbugs With Polymeric Nanoparticles
Scientists at A*STAR and IBM Research – Almaden have developed biodegradable polymer nanoparticles that combat drug-resistant superbugs.
Clinical Trial Numbers In Australia Fall For Third Straight Year
New figures show that the number of new clinical trials in Australia has fallen by 13 percent for three straight years.